发明名称 TREATING AGENT OF HYPERTONIC DISEASE
摘要 <P>PROBLEM TO BE SOLVED: To examine by comparing neuromuscular transmission inhibitory activity and treatment index of an M-form with a mixture of an L-form and LL-form of type A botulinus toxin. <P>SOLUTION: The M-form of the type A botulinus toxin has characteristics such as (1) excellent in the neuromuscular transmission inhibitory activity, (2) having a high treatment index, (3) having a low antigenicity, and (4) without attenuating its effect by repeated administration as compared with those of the mixture of its L-form and LL-form, and therefore especially useful as a treating agent of diseases caused by hypertonia such as strabismus, blepharospasm, one-sided facial spasm, spastic torticollis, paralysis after stroke, infantile cerebral palsy, spastic aphonia, head ache, lumbago, neck pain, back pain, stiff shoulder, muscular relaxation failure occurring on getting Parkinsonian disease or multiple sclerosis, fascia pain syndrome, spasm of mastication muscle, chronic anal fissure, urinary incontinence, bruxism, facial myokymia, tic, local dystonia, wrinkles, etc. <P>COPYRIGHT: (C)2005,JPO&NCIPI
申请公布号 JP2005154407(A) 申请公布日期 2005.06.16
申请号 JP20040180424 申请日期 2004.06.18
申请人 SANTEN PHARMACEUT CO LTD 发明人 OZAKI SHUNJI;SUGIMOTO HIROSHI;SHIMAZAWA MASAMITSU;HARA HIDEAKI
分类号 A61K38/00;A61K35/74;A61P1/00;A61P13/00;A61P17/00;A61P21/02;A61P25/00;A61P25/02;A61P25/14;A61P25/16;A61P27/02;A61P29/00 主分类号 A61K38/00
代理机构 代理人
主权项
地址